×

Transcat Relocates to State-of-the-Art Calibration Laboratory in Los Angeles, California

ROCHESTER, N.Y., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Transcat, Inc. (Nasdaq:TRNS) announced today that it has relocated its Los Angeles laboratory from Anaheim to a larger, updated service facility in Fullerton, California. Transcat is a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation.

Transcat's new laboratory located at 1503 Orangethrope Avenue, Fullerton, CA Phone: 714.447.4445


A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=30571

Lee D. Rudow, President and Chief Executive Officer, commented, "Our newly relocated Los Angeles calibration lab is a state-of-the-art facility in the heart of Southern California's life sciences cluster. In addition to being larger to accommodate customer demand, the lab has enhanced capabilities with additional metrology equipment and is staffed with highly experienced technicians. The location is ideal as it provides greater flexibility for customers representing the wealth of life sciences, healthcare, aerospace and technology manufacturing companies in the area. We are excited to continue to provide the responsive and high quality service our customers have come to expect from us in this dynamic market."

In addition to the strategic location of the new laboratory, the lab's enhanced capabilities include primary/reference mass capability, a Thunder Scientific humidity chamber, a single axis vision system, advanced torque capability and improved pressure capabilities. The Los Angeles laboratory provides calibration services as part of Transcat's network of labs for over 119,000 instruments from more than 7,800 manufacturers, including expertise in dimensional, electrical, RF, temperature/humidity, pressure, vacuum, flow, precision mass, torque, optics and more. Transcat's 18 laboratories, located throughout the United States, Canada and Puerto Rico, are ISO/IEC 17025 Accredited and in compliance with the requirements of ISO 9001:2008, ISO TS16949:2009, ANSI/NCSL Z540.1-1994, and ISO10012:2003.

Transcat will host an open house event at the new Los Angeles facility on March 19, 2015, in conjunction with the Measurement Science Conference being held at the Disneyland resort. Transportation to and from the conference will be provided. For further details, please visit us at www.Transcat.com.

The new lab is located at 1503 East Orangethrope Avenue, Unit A, Fullerton, CA 92831.

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration and compliance services, including analytical instrument qualifications, equipment and process validation. The Company is focused on providing best-in-class calibration analytics to highly regulated industries, particularly healthcare, which includes companies in pharmaceuticals, medical devices and bioscience. With 18 strategically-located centers of excellence in the United States, Canada and Puerto Rico, Transcat performs over 200,000 specialized technical services annually. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also answers the call with cGMP and GLP compliant services.

In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation, marketing more than 100,000 premier and propriety brand instruments to nearly 30,000 customers.

Transcat's growth strategy is to leverage its service capabilities, strong brand and leading distribution platform to drive organic sales growth and to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found on its website at: Transcat.com

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions that often are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "could," and other similar words. All statements addressing operating performance, events, or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to growth and staffing are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties which are more fully described in Transcat's Annual and Quarterly Reports filed with the Securities and Exchange Commission. In light of these risks and assumptions made by the Company, actual results may vary materially from those currently anticipated and undue reliance should not be placed on the Company's forward-looking statements. Except as required by law, the Company disclaims any obligation to update any forward-looking statements contained in this press release.

CONTACT: For more information, contact: Company: Roman Melnyk Manager, Marketing Operations (585) 352-9720 x3410 rmelnyk@transcat.com Media: Brandonne Rankin, MPS McDougall Communications (585) 441-0202 brankin@mcdougallpr.com Investors: Deborah K. Pawlowski Kei Advisors LLC (716) 843-3908 dpawlowski@keiadvisors.comSource:Transcat, Inc.